Expert Consensus Statement on an Updated Definition of Unintended Weight Loss Among Persons With Human Immunodeficiency Virus in the Modern Treatment Era
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciae407 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Roger Bedimo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Weight Loss, HIV Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EMD Serono, Inc..
Abstract (Originalsprache)
The era of modern antiretroviral therapy (ART) has markedly improved health and survival among persons with human immunodeficiency virus (HIV) (PWH). In the pre-ART era, wasting was associated with HIV disease progression to acquired immunodeficiency syndrome and death. Effective ART has reduced the prevalence and incidence of this pre-ART form of HIV-associated wasting. However, a subgroup of ART-treated virally suppressed PWH continue to lose weight, often accompanied by aging-related comorbidities and/or functional deficits. For this subgroup of patients, the older definition of HIV-associated wasting (HIVAW) cannot and should not be applied. An expert panel comprising the authors of this white paper convened to review the existing definition of HIVAW and to create an updated definition that they termed HIV-associated weight loss, based on clinically defined parameters among contemporary PWH receiving ART. Here, clinical features and laboratory biomarkers associated with HIV-associated weight loss are reviewed and approaches to screening and treatment are considered. Available management approaches, including the use of current US Food and Drug Administration–approved medications for HIVAW and other available therapies are discussed. The expert panel also identified knowledge gaps and provided recommendations for clinicians, payers, and researchers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Division of Infectious Diseases, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- Owen Clinic, University of California San Diego Health, San Diego, California, USA.
- Infectious Diseases Division, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
ORCID-Profile: Daniel Lee
Förderung
- EMD Serono, Inc.
Zitieren
APA
Bedimo, R., Hardy, D., Lee, D., Palella, F., & Wohl, D. (2024). Expert Consensus Statement on an Updated Definition of Unintended Weight Loss Among Persons With Human Immunodeficiency Virus in the Modern Treatment Era. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae407
Vancouver
Bedimo R, Hardy D, Lee D, Palella F, Wohl D. Expert Consensus Statement on an Updated Definition of Unintended Weight Loss Among Persons With Human Immunodeficiency Virus in the Modern Treatment Era. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae407
BibTeX
@article{Bedimo2024,
author = {Bedimo, Roger and Hardy, David and Lee, Daniel and Palella, Frank and Wohl, David},
title = {Expert Consensus Statement on an Updated Definition of Unintended Weight Loss Among Persons With Human Immunodeficiency Virus in the Modern Treatment Era},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciae407}
}
EUVIMED